Skip to main content
. 2021 Sep 21;9:726716. doi: 10.3389/fcell.2021.726716

FIGURE 4.

FIGURE 4

Validation of the IRlncRNAPs signature. (A) RiskScore distribution of GC patients. (B) Survival status of GC patients with increasing riskScore. (C) Univariate and (D) multivariate Cox regression analyses of the riskScore.